Celanese Q2 2026 earnings and results

Quarter results

Celanese reported second-quarter 2026 U.S. GAAP diluted EPS of $1.15 and adjusted EPS of $2.45 on net sales of $2.8 billion, an 18% sequential increase driven by a 4% volume gain and 14% pricing improvement. Consolidated operating profit was $276 million; adjusted EBIT was $470 million and operating EBITDA was $649 million, with margins of 10%, 17% and 24%, respectively.

Engineered Materials

Engineered Materials posted net sales of $1.45 billion, up 9% sequentially (3% volume, 6% price), with operating profit of $156 million, adjusted EBIT of $234 million and operating EBITDA of $335 million (margins 11%, 16%, 23%). Results reflected commercial execution and momentum in medical and electronics. The business completed the Ulsan compounding unit closure, finished a nylon 6,6 network optimization ahead of schedule, and executed a major POM turnaround. Aisan Industry Kentucky adopted Celanese POM ECO-C for fuel pump modules.

Acetyl Chain

The Acetyl Chain delivered net sales of $1.33 billion, a 28% sequential increase (6% volume, 22% price), with operating profit of $237 million, adjusted EBIT of $321 million and operating EBITDA of $385 million (margins 18%, 24%, 29%). The business captured pricing and margin opportunities, completed a rapid restart of the Frankfurt VAM unit, and pursued downstream growth initiatives including a collaboration with Siegwerk on bio‑based ethyl acetate.

Portfolio, cash and outlook

Celanese said footprint and productivity actions—including the Ulsan closure and planned Lanaken acetate tow closure—are expected to deliver more than $50 million of annualized fixed‑cost savings. Second‑quarter operating cash flow was $209 million and free cash flow $140 million. The effective tax rate was 8% for GAAP and adjusted earnings, and management expects that rate for the full year. Third‑quarter adjusted EPS is forecast at $1.35–$1.75, with full‑year adjusted EPS around $6.00 and free cash flow of $700–$800 million.